Last reviewed · How we verify
NCT07211672
Clinical Implementation of Multichannel Functional Electrical Stimulation Device for Gait Rehabilitation in Subchronic Stroke: A Feasibility Study
NA trial testing Multichannel functionnal electrical stimulation in Stroke Sequelae in 5 participants. Not yet recruiting.
1 September 2026
Quick facts
| Lead sponsor | TOPMED |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 5 |
| Start date | 31 October 2025 |
| Primary completion | 1 September 2026 |
| Estimated completion | 28 February 2027 |
Drugs / interventions tested
- Multichannel functionnal electrical stimulation
Conditions studied
- Stroke Sequelae — all drugs for Stroke Sequelae →
- Stroke ( 3 Months After Onset) — all drugs for Stroke ( 3 Months After Onset) →
Sponsor
TOPMED
Who can join
18 and older, any sex, with Stroke Sequelae or Stroke ( 3 Months After Onset). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this interventional study is to evaluate the effect of multichannel functionnal electrical stimulation for subchronic stroke gait rehabilitation. The main questions it aims to answer are: * Does this new therapy help improve walking speed? * Evaluate other aspects of therapeutic effectiveness such as different aspects of walking endurance, mobility, postural instability and autonomy. * Evaluate physiological aspects of autonomous gait such as spasticity, muscle strength and motor and sensorimotor recovery. * Evaluate the acceptability of this new therapy and its effect on quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07211672
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke Sequelae
Currently open trials in the same condition.
- NCT07113067 — Accelerated rTMS vs. Sham for Stroke Apathy · Phase 1, PHASE2 · recruiting
- NCT06797154 — A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Subacute Stroke Survivors · NA · recruiting
- NCT05626894 — Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors · Phase 2 · recruiting
- NCT06289569 — Home Tele Rehabilitation Therapy for Vascular Dementia · NA · recruiting
- NCT06593184 — Efficacy of Trans-spinal Magnetic Stimulation on Functional Mobility in Chronic Stroke Patients · NA · recruiting
Other TOPMED trials
Trials by the same sponsor.
- NCT07084974 — Evaluation of Trunk Assistance Exoskeleton · NA · recruiting
- NCT06655558 — Validating the Clinical Effect of a Knee Orthosis · NA · terminated
- NCT06441877 — Community Spirit in Residence for the Elderly · completed
- NCT06115161 — Development and Validation of an Instrumented Ankle-foot Orthosis · NA · withdrawn
- NCT06076148 — Virtual Reality and Technologies for Elderly · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07211672 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TOPMED
- Last refreshed: 8 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07211672.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing